PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 2535925

  • 1. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia.
    Gwirtsman HE, Kaye WH, George DT, Jimerson DC, Ebert MH, Gold PW.
    Arch Gen Psychiatry; 1989 Jan; 46(1):61-9. PubMed ID: 2535925
    [Abstract] [Full Text] [Related]

  • 2. Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients.
    Kling MA, Demitrack MA, Whitfield HJ, Kalogeras KT, Listwak SJ, DeBellis MD, Chrousos GP, Gold PW, Brandt HA.
    Neuroendocrinology; 1993 Jun; 57(6):1082-91. PubMed ID: 8232766
    [Abstract] [Full Text] [Related]

  • 3. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
    Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.
    Psychoneuroendocrinology; 1988 Jun; 13(3):265-72. PubMed ID: 2900533
    [Abstract] [Full Text] [Related]

  • 4. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism.
    Mortola JF, Rasmussen DD, Yen SS.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):517-22. PubMed ID: 2537336
    [Abstract] [Full Text] [Related]

  • 5. Circadian variations in plasma ACTH, cortisol and beta-endorphin levels in normal-weight bulimic women.
    Vescovi PP, Rastelli G, Volpi R, Chiodera P, Di Gennaro C, Coiro V.
    Neuropsychobiology; 1996 Mar; 33(2):71-5. PubMed ID: 8927231
    [Abstract] [Full Text] [Related]

  • 6. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.
    Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, Jimerson D, Ebert M, Rittmaster R, Loriaux DL.
    N Engl J Med; 1986 May 22; 314(21):1335-42. PubMed ID: 3010109
    [Abstract] [Full Text] [Related]

  • 7. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia.
    Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH.
    Psychoneuroendocrinology; 1987 May 22; 12(2):131-40. PubMed ID: 3037583
    [Abstract] [Full Text] [Related]

  • 8. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.
    Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F.
    Eur J Endocrinol; 2001 Aug 22; 145(2):165-71. PubMed ID: 11454512
    [Abstract] [Full Text] [Related]

  • 9. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes.
    Monteleone P, Di Lieto A, Tortorella A, Longobardi N, Maj M.
    Psychiatry Res; 2000 May 15; 94(2):121-9. PubMed ID: 10808037
    [Abstract] [Full Text] [Related]

  • 10. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
    Hotta M, Shibasaki T, Masuda A, Imaki T, Demura H, Ling N, Shizume K.
    J Clin Endocrinol Metab; 1986 Feb 15; 62(2):319-24. PubMed ID: 3001125
    [Abstract] [Full Text] [Related]

  • 11. Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa.
    Lanfranco F, Gianotti L, Picu A, Giordano R, Daga GA, Mondelli V, Malfi G, Fassino S, Ghigo E, Arvat E.
    Eur J Endocrinol; 2006 May 15; 154(5):731-8. PubMed ID: 16645021
    [Abstract] [Full Text] [Related]

  • 12. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.
    Kaye WH, Berrettini WH, Gwirtsman HE, Chretien M, Gold PW, George DT, Jimerson DC, Ebert MH.
    Life Sci; 1987 Nov 02; 41(18):2147-55. PubMed ID: 2823041
    [Abstract] [Full Text] [Related]

  • 13. Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery.
    Winterer J, Gwirtsman HE, George DT, Kaye WH, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1985 Oct 02; 61(4):693-7. PubMed ID: 2993344
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamic pituitary adrenal function in patients with anorexia nervosa.
    Takahara J, Hosogi H, Yunoki S, Hashimoto K, Uneki T.
    Endocrinol Jpn; 1976 Dec 02; 23(6):451-6. PubMed ID: 191248
    [Abstract] [Full Text] [Related]

  • 15. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA, Lesem MD, Listwak SJ, Brandt HA, Jimerson DC, Gold PW.
    Am J Psychiatry; 1990 Jul 02; 147(7):882-6. PubMed ID: 2356873
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa.
    Monteleone P, Luisi M, Colurcio B, Casarosa E, Monteleone P, Ioime R, Genazzani AR, Maj M.
    Psychosom Med; 2001 Jul 02; 63(1):62-8. PubMed ID: 11211066
    [Abstract] [Full Text] [Related]

  • 17. Immunoendocrine aspects of anorexia nervosa.
    Brambilla F, Ferrari E, Brunetta M, Peirone A, Draisci A, Sacerdote P, Panerai A.
    Psychiatry Res; 1996 Apr 16; 62(1):97-104. PubMed ID: 8739119
    [Abstract] [Full Text] [Related]

  • 18. Abnormal caloric requirements for weight maintenance in patients with anorexia and bulimia nervosa.
    Weltzin TE, Fernstrom MH, Hansen D, McConaha C, Kaye WH.
    Am J Psychiatry; 1991 Dec 16; 148(12):1675-82. PubMed ID: 1957930
    [Abstract] [Full Text] [Related]

  • 19. CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.
    Frank GK, Kaye WH, Altemus M, Greeno CG.
    Biol Psychiatry; 2000 Aug 15; 48(4):315-8. PubMed ID: 10960163
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb 15; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.